Position in SVTRnew
Snapshot 2026-10-20- Startup SignalsTop 50%
- Life SciencesTop 50%
- Medical Imaging#5of 16
About
Sirona Medical, founded in 2018 and headquartered in San Francisco, builds RadOS, a cloud-native radiology operating system unifying PACS archiving, diagnostic viewing, reporting, worklist and workflow AI for radiology practices and hospital imaging departments, and is launching Cortex, an agentic AI orchestration layer.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Founders / core team
Investors
Funding history
- 2026-10-15Series D+$40M
Investors · Avidity Partners、8VC、GreatPoint Ventures、KLT、Rose Park Advisors
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Sirona Medical
Sirona Medical, founded in 2018 and headquartered in San Francisco, builds RadOS, a cloud-native radiology operating system unifying PACS archiving, diagnostic viewing, reporting, worklist and workflow AI for radiology practices and hospital imaging departments, and is launching Cortex, an agentic AI orchestration layer.
Series D+ · $150M · 2026-10
$150M
United States
BusinessLatest roundTotal raisedDate- Epsilon Health
Founded in 2024 and based in San Francisco, Epsilon Health is an "AI-native" radiology practice that embeds purpose-built AI directly into board-certified radiologists' diagnostic workflows, accelerating interpretation while preserving physician oversight and care quality. It currently reads 2,500+ imaging studies per day, has served 250,000+ patients, and handles more than half the imaging volume of one of the largest U.S. outpatient imaging providers.
Series A · 2026-09
— - Covera Health
Covera Health, founded in 2017 in New York, USA, uses AI and data analytics to help radiologists improve accuracy and reduce misdiagnoses. The company also completed the acquisition of CoRead, which uses AI to flag medical errors in radiology exams.
Series C · $50M · 2023-11
$50M - CARPL
CARPL, founded in 2021 in San Francisco, helps hospitals select and integrate AI radiology applications into radiologist workflows, offering the only platform with validation and monitoring capabilities that integrates with PACS workstations.
Undisclosed · $6M · 2024-02
$6M
China
BusinessLatest roundTotal raisedDate- 冰晶医智
Bingjing Medical Intelligence (Suzhou Bingjing Intelligent Medical Technology Co., Ltd.), founded in 2021 in Suzhou, China, develops cardiovascular interventional imaging and intracardiac echocardiography (ICE) devices.
Series A · $139M · 2026-06
$139M - 深睿医疗
Shenzhen Deepwise Technology, founded in 2017 in Beijing, China, develops AI-powered medical imaging systems.
Series A · $73M · 2025-01
$73M - 慧创医疗
Huichuang Medical, founded in 2016 in Danyang, China, develops and commercializes brain-function medical devices. Its core product is a near-infrared brain imaging system that performs high-resolution quantitative brain function assessment while patients are in motion, speaking, or undergoing treatment.
Series B · $152M · 2024-06
$152M
Europe
BusinessLatest roundTotal raisedDate- Deepc
Deepc, founded in 2019 in Munich, Germany, improves radiology workflows by integrating various AI tools, enabling radiologists to analyze medical images more efficiently.
Series A · $13M · 2024-07
$13M - Quibim
Quibim, founded in 2012 in Valencia, Spain, applies AI to analyze MRI, CT, and PET scans to assist doctors in diagnosing cancers and neurological diseases, with 170 installations globally.
Series A · $50M · 2025-02
$50M - Raidium
Raidium, founded in 2021 in France, develops an AI-powered platform that helps radiologists analyze medical images more efficiently and accurately. Raidium has developed the world's first radiology AI-native foundation model, delivering detailed 3D segmentation, advanced measurements, and automated analysis of complex biomarkers at unprecedented speed—2,500 times faster than manual methods.
Undisclosed · $13M · 2024-12
$13M
Other / unspecified
BusinessLatest roundTotal raisedDate- Harrison.ai
Harrison.ai, founded in 2017 in Sydney, Australia, develops AI tools to help doctors interpret medical images such as X-rays, CT scans, and pathology slides faster and more accurately. The company offers Annalise.ai for radiology and Franklin.ai for pathology. Annalise.ai currently operates in over 1,000 healthcare institutions across multiple countries, supporting more than 6 million patients annually.
Series C · $112M · 2025-05
$112M - Qure.AI
Qure.AI, founded in 2016 in Mumbai, India, analyzes X-rays, CT scans, and other radiology images to detect abnormalities such as lung disease, stroke, and trauma.
Undisclosed · $65M · 2024-09
$65M - UltraSight
UltraSight, founded in 2018 as a joint venture of the Weizmann Institute of Science and NYU Grossman School of Medicine (formerly OnSight Medical), builds Echosystem, an FDA 510(k)-cleared AI-guided cardiac ultrasound workflow platform that lets non-specialist clinicians perform diagnostic-quality bedside echocardiography under physician oversight. It is deployed across more than 10 U.S. commercial ICU sites.
Series B · $42M · 2026-09
$42M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
39 Life Sciences deals in the last 24 months · 7 at a nearby stage · 35 in 硅谷
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 3 at a nearby stage · 31 in 硅谷
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 10 at a nearby stage · 22 in 硅谷
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 6 at a nearby stage · 20 in 硅谷
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 8 at a nearby stage · 15 in 硅谷
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 5 at a nearby stage · 14 in 硅谷
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.